Magnesium and QTc
(Die Seite wurde neu angelegt: „{{bibi|TI=Mg - QTc|S1=%22mg2%2B%22+OR+magnesium+OR+mgso4+OR+hypomagnes*+OR+hypermagnes*+OR+trpm7|S2=QT+time+OR+QT+prolongation+OR+QT+dispersion+OR+QT+time+OR+Q…“)
Aktuelle Version vom 1. September 2020, 08:56 Uhr
Mg - QTc
- THIS %22mg2%2B%22+OR+magnesium+OR+mgso4+OR+hypomagnes*+OR+hypermagnes*+OR+trpm7
- AND QT+time+OR+QT+prolongation+OR+QT+dispersion+OR+QT+time+OR+QT+prolongation+OR+QT+dispersion+OR+OR+lqt*+OR+long+qt+OR+early+afterdepolari*+OR+early+after-depolari*+OR+torsade+de+pointes+OR+%22kir2.1%22+OR+%22kv4.2%22+OR+hERG
- NOT
- PubMed: 08/05/20 PMCentral: ----
- search on moremed.org
22174173 2011. A rare electrocardiographic manifestation of a rare form of multiple electrolyte disturbances: hyperparathyroid crisis.
8209703 1994. Hepatite aguda alcoolica complicada com arritmia cardiaca. Alcool, hepatite, hipomagnesiemia, torsade de pointes, corticoterapia.
1539780 1992. Torsade de pointes and long QT syndrome following major blood transfusion.
24303973 2013. Licorice-induced severe hypokalemia with recurrent torsade de pointes.
32389016 2020. Torsade de pointes in initiating hemodialysis: a case report.
14666271 2003. Female alcoholics: electrocardiographic changes and associated metabolic and electrolytic disorders.
23060109 2012. Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss?
21452253 2011. Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus.
25815024 2014. Methadone induced torsades de pointes and ventricular fibrillation: A case review.
22947859 2012. Multi-ion distributions in the cytoplasmic domain of inward rectifier potassium channels.
20712994 2010. Phosphatidylinositol-4,5-bisphosphate (PIP(2)) stabilizes the open pore conformation of the Kv11.1 (hERG) channel.
11566776 2001. Unitary conductance variation in Kir2.1 and in cardiac inward rectifier potassium channels.
9788926 1998. Interaction of Ba2+ with the pores of the cloned inward rectifier K+ channels Kir2.1 expressed in Xenopus oocytes.
8842207 1996. [K+] dependence of open-channel conductance in cloned inward rectifier potassium channels (IRK1, Kir2.1).
31783793 2019. Prevalence and risk factors of prolonged corrected QT interval in general Chinese population.
30157775 2018. Effect of serum electrolytes within normal ranges on QTc prolongation: a cross-sectional study in a Chinese rural general population.
30999887 2019. Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.
27797880 2016. Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction.
24121811 2013. Overdrive pacing in a patient with incessant torsades de pointes.
22987900 2012. Severe primary hypothyroidism presenting with torsades de pointes.
23203174 2012. Syncope in a patient being treated for hepatic and intestinal amoebiasis.
32169926 2020. Drug use and torsades de pointes cardiac arrhythmias in Sweden: a nationwide register-based cohort study.
2467681 1989. Electrocardiographic findings and frequency of arrhythmias in Bartter's syndrome.
26183037 2016. Pharmacological treatment of acquired QT prolongation and torsades de pointes.
19812810 2009. A sweet tooth as the root cause of cardiac arrest.
27212965 2016. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.
29304463 2018. Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.
22825908 2012. QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature.
21660912 2011. Electrolyte disorders and arrhythmogenesis.
28357022 2012. Failure to Treat Torsades de Pointes.
24428853 2014. Antibiotic-induced cardiac arrhythmias.
18690045 2007. Differences between ion binding to eag and HERG voltage sensors contribute to differential regulation of activation and deactivation gating.
32554946 2020. Magnesium Deficiency Causes Transcriptional Downregulation of Kir2.1 and Kv4.2 Channels in Cardiomyocytes Resulting in QT Interval Prolongation.
10526691 1999. Prolongation of the QT interval in children with liver failure.
9068917 1997. A practical approach to torsade de pointes.
7902224 1993. Torsade de pointes.
8269653 1993. Magnesium and the heart: antiarrhythmic therapy with magnesium.
8416758 1993. Abnormal QT intervals associated with negative T waves induced by antiarrhythmic drugs are rapidly reduced using magnesium sulfate as an antidote.
1551265 1992. Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia.
1660796 1991. Acute effects of the ACE inhibitor lisinopril on cardiac electrophysiological parameters of isolated guinea pig hearts.
26251626 2015. Serum magnesium concentrations in patients receiving sodium picosulfate and magnesium citrate bowel preparation: an assessment of renal function and electrocardiographic conduction.
26069818 2012. Magnesium in disease.
29849428 2017. Methadone-induced Torsades de Pointes Masquerading as Seizures.
32670733 2020. Magnesium Supplementation Shortens Hemodialysis-Associated Prolonged QT.
22114630 2011. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes.
12101132 2002. The role of magnesium in the emergency department.
31911979 2019. Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report.
24940425 2014. Increasing gap junction coupling suppresses ibutilide-induced torsades de pointes.
29731714 2018. Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes.
30270992 2018. Effect of Hemodialysis on Corrected QT Interval and QTc Dispersion.
22529489 2012. Phenytoin in treatment of amiodarone-induced Torsades de pointes.
19646241 2009. Prolonged QT interval in a man with anorexia nervosa.
30305584 2018. Persistent QT Prolongation in a Child with Gitelman Syndrome and SCN5A H558R Polymorphism.
20720356 2010. Premature atrial contraction induces torsades de pointes in a patient of Takotsubo cardiomyopathy with QT prolongation.
9372331 1997. Torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in acute myelogenous leukemia.
19377216 2008. Improvement of maximum corrected QT and corrected QT dispersion in electrocardiography after kidney transplantation.
28471572 2016. Magnesium-Responsive Polymorphic Ventricular Tachycardia Associated with Alcoholic Binge Drinking.
31221261 2019. Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals.
11583899 2001. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.
2661626 1989. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?
3711493 1986. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans.
6630761 1983. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.
26802105 2016. Serum Magnesium and the Risk of Death From Coronary Heart Disease and Sudden Cardiac Death.
10361868 1999. QT dispersion in patients with end-stage renal failure and during hemodialysis.
10405219 1999. Hypomagnesemia.
29021858 2017. Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia.
19944332 2009. Torsades de Pointes with QT prolongation related to donepezil use.
24653589 2013. Torsade de pointes as a reperfusion arrhythmia following intravenous thrombolytic therapy.
22394705 2012. Pseudohypoparathyroidism presenting with ventricular arrhythmia: a case report.
16533896 2006. Functional roles of charged amino acid residues on the wall of the cytoplasmic pore of Kir2.1.
12407079 2002. Ser165 in the second transmembrane region of the Kir2.1 channel determines its susceptibility to blockade by intracellular Mg2+.
9382895 1997. A conserved arginine residue in the pore region of an inward rectifier K channel (IRK1) as an external barrier for cationic blockers.
8740374 1996. Fast inactivation causes rectification of the IKr channel.
10205594 1999. Life-threatening ventricular tachycardia due to liquorice-induced hypokalaemia.
11410700 2001. A case of torsade de pointes associated with hypopituitarism due to hemorrhagic fever with renal syndrome.
18821491 2008. Cardiotoxicity after massive amantadine overdose.
18570170 2008. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest.
20015154 2010. Cholesterol modulates ion channels via down-regulation of phosphatidylinositol 4,5-bisphosphate.
15618275 2005. Two Kir2.1 channel populations with different sensitivities to Mg(2+) and polyamine block: a model for the cardiac strong inward rectifier K(+) channel.
12205194 2002. Cytosolic Ca2+ triggers early afterdepolarizations and Torsade de Pointes in rabbit hearts with type 2 long QT syndrome.
12411513 2002. Identification of a site involved in the block by extracellular Mg(2+) and Ba(2+) as well as permeation of K(+) in the Kir2.1 K(+) channel.
10066894 1999. Kir2.1 encodes the inward rectifier potassium channel in rat arterial smooth muscle cells.
9508824 1998. Voltage-dependent blockade of HERG channels expressed in Xenopus oocytes by external Ca2+ and Mg2+.
7884731 1994. Torsades de pointes-like polymorphic ventricular tachycardia in a dog.
29759319 2015. Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures.
10875735 2000. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential.
12110021 2002. Electrocardiogram with prolonged QT interval in Gitelman disease.
30596175 2019. Clinical and Genetic Characteristics in Patients With Gitelman Syndrome.
23755081 2013. Acquired Long QT Syndrome Manifesting with Torsades de Pointes in a Patient with Panhypopituitarism due to Radiotherapy.
25558343 2014. Ventricular arrhythmia in patients with prolonged QT interval during liver transplantation: two cases report.
24578711 2014. Channelopathies.
21977140 2010. Polymorphic ventricular tachycardia in acute myocardial infarction treated by thrombolysis: reperfusion, complication or iatrogenic sign?
25967879 2015. The relationship between repolarization parameters and serum electrolyte levels in patients with J wave syndromes.
26878253 2015. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
20353903 2010. Magnesium and cardiovascular system.
30558036 2018. Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias: A case report.
29245320 2017. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.
30169383 2019. Critical Consideration of Myxedema Coma in the Postoperative Setting: A Case Report.
25470888 2014. A comparison of the effects of lidocaine or magnesium sulfate on hemodynamic response and QT dispersion related with intubation in patients with hypertension.
24397608 2014. Drug-induced long QT syndrome and fatal arrhythmias in the intensive care unit.
11942876 2002. Perioperative management of long QT syndrome in a child with congenital heart disease.
20128168 2009. Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes.
30220246 2019. Hypomagnesemia and hypermagnesemia.
24697004 2013. A case of recurrent arrhythmia in an acute pancreatitis patient--pathophysiological explanation using shortage of 'repolarization reserve'.
3993440 1985. The relationship between QTc changes and nutrition during weight loss after gastroplasty.
10830458 2000. Heart risk associated with weight loss in anorexia nervosa and eating disorders: electrocardiographic changes during the early phase of refeeding.
16156840 2005. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine.
12534434 2003. The importance of the QT interval: a review of the literature.
7572567 1995. Torsades de pointes and long QT syndromes.
17540188 2007. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes.
14597941 2003. Evaluation of the dofetilide risk-management program.
11773906 2002. Long QT syndrome: diagnosis and management.
2729056 1989. Effect of the infusion of magnesium sulfate during atrial pacing on ECG intervals, serum electrolytes, and blood pressure.
49775 1975. Letter: Glycerol in cerebral oedema.
31942276 2020. Mirtazapine's effect on the QT interval in medically hospitalized patients.
22470374 2011. QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory.
27471598 2016. Hypomagnesemia as a potentially life-threatening adverse effect of omeprazole.
24155819 2012. Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation.
25350118 2014. Lack of negatively charged residues at the external mouth of Kir2.2 channels enable the voltage-dependent block by external Mg2+.
24681627 2014. A long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation.
12151568 2002. Changes in the corrected QT interval and corrected QT dispersion during haemodialysis.
1409197 1992. Sotalol-induced torsade de pointes: management with magnesium infusion.
3341171 1988. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease.
3766386 1986. Efficacy of magnesium sulfate in the treatment of torsade de pointes.
3966318 1985. Torsade de pointes and magnesium deficiency.
20723644 2010. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
12767447 2003. Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome.
12586278 2003. Effect of short- and long-duration spaceflight on QTc intervals in healthy astronauts.
9354415 1997. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.
2296905 1990. Magnesium sulfate is the treatment for torsades de pointes if the right dose is given.
2729150 1989. Treatment of torsade de pointes with intravenous magnesium.
2650516 1989. Magnesium treatment of ventricular arrhythmias.
6695782 1984. Magnesium therapy for torsades de pointes.
6650429 1983. Hypomagnesemic torsades de pointes.
14728075 2003. Does magnesium have a role in the treatment of patients with coronary artery disease?
8358483 1993. The importance of magnesium in cardiovascular disease.
27914889 2017. Ventricular tachycardia and prolonged QT interval presenting as seizure-like activity.
24462399 2014. The use of isoproterenol and phenytoin to reverse torsade de pointes.
23896010 2013. Citalopram and levosulpiride: a dangerous drug combination for QT prolongation.
21075581 2012. Isoproterenol as an adjunct for treatment of idiopathic ventricular fibrillation storm in a pregnant woman.
20006210 2010. Termination of drug-induced torsades de pointes with overdrive pacing.
19857426 2009. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.
9928709 1999. Torsades de pointes: a case with multiple variables.
7945604 1994. Torsades de pointes induced by erythromycin and terfenadine.
2914039 1989. Magnesium sulfate termination of torsades de pointes following failure of cardioversion.
7733096 1995. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance.
18359968 2008. Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosis.
15119574 2004. Model of effect of magnesium prophylaxis on frequency of torsades de pointes in ibutilide-treated patients.
8438899 1993. Induction of hypomagnesemia during Amsacrine treatment.
25864370 2015. Magnesium and Dialysis: The Neglected Cation.
25828570 2015. Dialysate and serum potassium in hemodialysis.
12500237 2003. Cell-associated magnesium and QT dispersion in hemodialysis patients.
27639872 2017. Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit.
11812408 2002. Clinical and therapeutic aspects of congenital and acquired long QT syndrome.
3499072 1987. Torsade de pointes during administration of pentamidine isethionate.
3565423 1987. Effects of low potassium or magnesium concentrations on isolated cardiac tissue.
20610973 2010. A dyshomeostasis of electrolytes and trace elements in acute stressor states: impact on the heart.
7771501 1995. Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication.
8475949 1993. Case report: pentamidine and polymorphic ventricular tachycardia revisited.
12832258 2003. Side effects of ziprasidone.
14704599 2004. Ciprofloxacin- and hypocalcemia-induced torsade de pointes triggered by hemodialysis.
12845389 2003. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.
11304665 2001. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography.
11197564 2001. Prevalence and prognostic importance of hypomagnesemia and hypocalcemia in horses that have colic surgery.
21364460 2011. Magnesium--essentials for anesthesiologists.
2301766 1990. The effect of magnesium sulfate administration on cerebral and cardiac toxicity of bupivacaine in dogs.
12678199 2003. Amiodarone-induced torsade de pointes during bladder irrigation: an unusual presentation--a case report.
10870859 2000. Increased QT interval dispersion after hemodialysis: role of peridialytic electrolyte gradients.
2389840 1990. Magnesium treatment of torsade de pointes--a case report.
2629617 1989. Proprietes electrophysiologiques cliniques du magnesium et correlations avec son efficacite anti-arythmique dans les torsades de pointe acquises.
8599503 1996. Magnesium sulfate for conversion of supraventricular tachycardia refractory to intravenous adenosine.
2817575 1989. Magnesium sulfate & torsade de pointes.
3304038 1987. Torsades de pointes: atypical rhythm, atypical treatment.
8572407 1995. Indications du magnesium en anesthesie-reanimation.
1363741 1992. Effets arythmogenes du chlorydrate de sultopride: correlation clinique et electrophysiologique cellulaire.
2418718 1985. Torsades de pointe et hypomagnesemie.
7469224 1981. Torsades de pointes.
3152846 1988. Il solfato di magnesio nella terapia della tachicardia ventricolare a torsione di punta.
24285766 2013. Azithromycin-induced proarrhythmia and cardiovascular death.
23362038 2013. Torsades de pointes after administration of low-dose aripiprazole.
10534216 1999. Haloperidol-induced torsade de pointes.
1477438 1992. Prolonged recurrence of pentamidine-induced torsades de pointes.
7786143 1995. Mecanisme d'action des antiarythmiques de classe III.
8267505 1993. Les torsades de pointes.
1550438 1992. Effets du magnesium sur les post-depolarisations precoces et l'activite declenchee induites par le cesium sur les fibres de Purkinje de furet.
3122681 1987. Effets electrophysiologiques du sulfate de magnesium intraveineux chez l'homme.
3087320 1986. Effets anti-arythmiques du sulfate de magnesium intraveineux dans les torsades de pointes. A propos de 6 observations.
3096233 1986. Traitement des torsades de pointes par magnesium intraveineux.
28766238 2017. Magnesium isoglycyrrhizinate inhibits L-type Ca(2+) channels, Ca(2+) transients, and contractility but not hERG K(+) channels.
14692159 2003. Torsades de pointes following cardioversion: case history and literature review.
2196873 1990. Proarrhythmic actions of antiarrhythmic drugs: a review.
9782371 1998. Generating and influencing Torsades de Pointes--like polymorphic ventricular tachycardia in isolated guinea pig hearts.
19653656 2009. Ion-blocking sites of the Kir2.1 channel revealed by multiscale modeling.
22057978 2012. Inhibition of sodium current by taurine magnesium coordination compound prevents cesium chloride-induced arrhythmias.
19655100 2010. Clinical effects of cesium intake.
10958097 2000. Management of prolonged QT interval during a massive transfusion: calcium, magnesium or both?
8595691 1995. Diuretic-induced hypokalaemia inducing torsades de pointes.
9627533 1998. Torsade de pointes with sotalol overdose treated successfully with lidocaine.
19935903 2009. Inhibitory effects of dauricine on early afterdepolarizations and L-type calcium current.
11007539 2000. Block of inwardly rectifying K+ currents by extracellular Mg2+ and Ba2+ in bovine pulmonary artery endothelial cells.
20544619 2010. Multifactorial QT interval prolongation.
14766022 2004. Vitamins, supplements, herbal medicines, and arrhythmias.
10348955 1998. Acquired QT Prolongation: Mechanisms and Implications.
2085823 1990. Magnesium and cardiac arrhythmias. Reappraisal of an old substance.
12652102 2002. The influence of magnesium on the electrophysiological effects of erythromycin in the isolated Guinea pig heart.
1854660 1991. Torsades de pointes: prevention and therapy.
1854659 1991. Terminology of torsades de pointes.
9231028 1997. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium.
9302346 1997. Magnesium abolishes inadequate kinetics of frequency adaptation of the Q-aT interval in the presence of sotalol.
8001044 1994. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts.
3256422 1988. Pharmacological response of quinidine induced early afterdepolarisations in canine cardiac Purkinje fibres: insights into underlying ionic mechanisms.
29873021 2018. The Effects of Lipid Emulsion, Magnesium Sulphate and Metoprolol in Amitriptyline-Induced Cardiovascular Toxicity in Rats.
25253561 2015. Analysis of an ECG record database reveals QT interval prolongation potential of famotidine in a large Korean population.
18690034 2007. Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome.
19433077 2009. Modulation of haloperidol induced electrophysiological alterations on cardiac action potential by various risk factors and gender difference.
8131528 1994. Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline.
15746441 2005. Impaired KCNQ1-KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome.
9598592 1998. Dynamic Ca2+-induced inward rectification of K+ current during the ventricular action potential.
9168780 1997. Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells.
7828315 1995. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block.
1914096 1991. Polymorphous ventricular tachycardia associated with acute myocardial infarction.
2917391 1989. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.
3370776 1988. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs.
3338130 1988. Treatment of torsade de pointes with magnesium sulfate.
22846359 2012. [Magnesium metabolism and therapeutic strategy in cardiovascular disease].
15692161 2005. [Heart rate variability, arrhythmia and magnesium in hemodialysis patients].
11453949 2001. Hyperthyroidism is associated with lengthening of ventricular repolarization.
16698131 2006. Tolerable infusion rate of citrate based on clinical signs and the electrocardiogram in conscious dogs.
2416504 1985. Drug-induced torsade de pointes.
15001976 2004. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
2974361 1988. Il problema della tachicardia ventricolare a torsione di punta e della sua razionale terapia.
27022002 2016. Not your regular high: cardiac dysrhythmias caused by loperamide.
20671821 2010. Causes and management of drug-induced long QT syndrome.
22299661 2012. The effect of different dialysate magnesium concentrations on QTc dispersion in hemodialysis patients.
26869275 2016. A synergistic blocking effect of Mg(2)(+) and spermine on the inward rectifier K(+) (Kir2.1) channel pore.
25630313 2014. Importance of QT interval in clinical practice.
31637554 2019. Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report.
15616901 2004. Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy.
32603470 2020. Acquired Long QT Syndrome after Acute Myocardial Infarction: A Rare but Potentially Fatal Entity.
25057346 2014. Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.
19907690 2009. Drugs, electrolytes and tako-tsubo cardiomyopathy: triple aetiology of acquired long QT syndrome and torsades de pointes.
25706450 2015. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
20199131 2010. A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine.
18363122 2008. Non-fatal ventricular dysrhythmias associated with severe salicylate toxicity.
22668123 2012. Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management.
21649448 2011. Assessing QT interval prolongation and its associated risks with antipsychotics.
2129926 1990. Torsades de Pointes.
17879860 2007. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities.
1989768 1991. Cardiac arrest secondary to emotional stress and torsade de pointes in a patient with associated magnesium and potassium deficiency.
3257726 1988. Torsade de pointes in a patient receiving intravenous vasopressin.
19281438 2009. The relationship between blood glucose level and QTc duration in the critically ill.
16573402 2002. Cardiac arrhythmias: diagnosis and management. The tachycardias.
12917054 2003. Advances in the acute pharmacologic management of cardiac arrhythmias.
24020938 2013. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
11096483 1999. Torsades de Pointes.
26249264 2015. QT interval prolongation associated with low magnesium in chronic alcoholics.
27241860 2017. The prevalence of QT prolongation in a population of patients with substance use disorders.
22702639 2012. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.
11994029 2002. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.
7727055 1994. Drug-induced torsade de pointes. Incidence, management and prevention.
8129865 1993. Class III antiarrhythmics in overdose. Presenting features and management principles.
10553703 1999. Toxicity of quinolones.
7510621 1994. Torsade de pointes. Mechanisms and management.
20210367 2010. Safety considerations of fluoroquinolones in the elderly: an update.
12641485 2003. Fluoroquinolones in the elderly: safety considerations.
11740632 2001. QT-Verlangerung und Torsade de pointes-Tachykardie bei Therapie mit Maprotilin. Differenzialdiagnostische und -therapeutische Aspekte.
7588195 1995. Wide complex tachycardia.
11217540 2000. Antipsychotiques et securite cardio-vasculaire: donnees actuelles sur les allongements de l'intervalle QT et le risque d'arythmies ventriculaires.
10099907 1999. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction.
8293755 1993. Early after-depolarizations and torsade de pointes: implications for the control of cardiac arrhythmias by prolonging repolarization.
27154527 2019. Severe Torsades de Pointes with acquired QT prolongation.
27634841 2017. Treating arrhythmias with adjunctive magnesium: identifying future research directions.
24817413 2014. Drug interactions and protease inhibitors used in the treatment of hepatitis C: how to manage?
10853872 2000. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.
18304526 2008. Use and abuse of QT and TRIaD in cardiac safety research: importance of study design and conduct.
22389418 2012. In-hospital monitoring of T-wave alternans in a case of amiodarone-induced torsade de pointes: clinical and methodologic insights.
19351630 2009. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
10362846 1999. Effect of extracellular cations on the inward rectifying K+ channels Kir2.1 and Kir3.1/Kir3.4.
23808631 2013. Hypomagnesemia and proton-pump inhibitors.
14585064 2003. Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.
31092056 2019. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias.
24147515 2013. Torsades de pointes following clarithromycin treatment.
14977544 2004. Magnesium in clinical medicine.
8458600 1993. Experimental models of torsades de pointes.
3436500 1987. I sali di magnesio nel trattamento della tachicardia ventricolare.
3556945 1986. Un caso di torsione di punta da ipomagnesiemia.
3556944 1986. "Torsione di punta" da antidepressivi triciclici. Descrizione di un caso clinico.
6532886 1984. Azione antiaritmica del solfato di magnesio nella aritmia ventricolare a "torsione di punta".
15750993 2004. Rischio aritmologico in pazienti emodializzati vs soggetti normali.
22847284 2012. Electrocardiographic, cardiac enzymes, and magnesium in patients with severe acute pancreatitis.
9888262 1999. Antiarrhythmic effects of magnesium on rat papillary muscle and guinea pig ventricular myocytes.
10461849 1999. Effects of nicardipine and bupivacaine on early after depolarization in rabbit sinoatrial node cells: a possible mechanism of bupivacaine-induced arrhythmias.
21411146 2011. Methadone-induced torsades de pointes: a twist of fate.
9333595 1997. Medikamentose antiarrhythmische Therapie. Ist eine orale adjuvante Therapie mit Elektrolyten sinnvoll?
9333593 1997. Magnesiummangel und Magnesiumsubstitution. Einfluss auf ventrikulare Herzrhythmusstorungen unterschiedlicher Atiologie.
9333592 1997. Einfluss von Magnesium auf anhaltende ventrikulare Tachykardien.
9333591 1997. Klinisch-elektrophysiologische Effekte von Magnesium, insbesondere bei supraventrikularen Tachykardien.
32025785 2020. Long- und Short-QT-Syndrome : Notfalltherapie und Sekundarprophylaxe.
9821023 1998. Q-T interval prolongation and pleomorphic ventricular tachyarrhythmia ('Torsade de pointes') in organophosphate poisoning: report of a case.
15586745 2004. Seventy-four defibrillations for sotalol-induced torsades de pointes.
3229780 1988. Magnesium sulfate therapy in torsades de pointes.
16096514 2005. Antipsychotic drugs and QT prolongation.
28100427 2017. The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis.
19136164 2010. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
15301901 2004. Magnesium in treatment of acute myocardial infarction.
15159030 2004. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.
15193823 2004. Female preponderance in ibutilide-induced torsade de pointes.
11203051 2000. Torsades de pointes due to multihormonal deficiency induced long QT syndrome.
2365519 1990. Magnesium sulphate for torsade de pointes in a patient with congenital long QT syndrome.
3744606 1986. Limited effect of magnesium sulphate on torsades de pointes ventricular tachycardia.
28012118 2017. Risk factors for QTc-prolongation: systematic review of the evidence.
9744153 1998. Hypomagnesaemia in postoperative patients: an important contributing factor in postoperative mortality.
21496406 2011. The use of first generation versus second generation antipsychotics as add-on or as switch treatment and its effect on QTC interval: the Italian experience in a real-world setting.
27943168 2017. Hemodialysis-induced repolarization abnormalities on ECG are influenced by serum calcium levels and ultrafiltration volumes.
12122531 2002. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
14689085 2003. Tetanie.
11305536 2001. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.
11760927 2001. Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).
17212573 2006. Acquired long QT syndrome secondary to cesium chloride supplement.
15466950 2004. Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome.
3537078 1986. Magnesium and cardiac arrhythmias: nutrient or drug?
15278621 1991. Effects of lidocaine and verapamil on early afterdepolarizations in isolated rabbit sinoatrial node.
15270138 2004. Drug-induced long QT syndrome and Torsade de Pointes.
10999172 1999. Hypomagnesemia with hypokalemia in an uncontrolled diabetic patient presenting with recurrent episodes of torsades de pointes.
17987843 2007. [Despite medication, overdrive pacing is required to stabilize the electrical storm associated with acute coronary syndrome: a case report].
9253694 1997. [Pheochromocytoma of the left retroperitoneal paraganglion associated with torsade de pointes: a case report].
26706796 2015. Sudden Cardiac Death and Disorders of the QT Interval: Anesthetic Implications and Focus on Perioperative Management.
12108503 2002. Beta-adrenergic stimulation of pig myocytes with decreased cytosolic free magnesium prolongs the action potential and enhances triggered activity.
10355707 1999. Macroscopic T wave alternans as a harbinger of sudden death.
9300294 1997. Tissue magnesium levels and the arrhythmic substrate in humans.
9363818 1997. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.
8269292 1993. Drug therapy for torsade de pointes.
22990234 2013. Beat-to-beat corrected QT analysis detects corrected QT prolongation in 50 consecutive telemetry-monitored patients.
17031266 2006. Role of autonomic nervous activity in the antiarrhythmic effects of magnesium sulfate in a canine model of polymorphic ventricular tachyarrhythmia associated with prolonged QT interval.
10028924 1999. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
10445681 1999. Female gender is a risk factor for torsades de pointes in an in vitro animal model.
9733356 1998. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.
7475058 1995. Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance.
7532749 1994. Effects of magnesium on polymorphic ventricular tachycardias induced by aconitine.
1697384 1990. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.
1691383 1990. Pharmacologic response of cesium-induced ventricular tachyarrhythmias in anesthetized dogs.
10684450 1997. Antiarrhythmic and Arrhythmogenic Actions of Varying Levels of Extracellular Magnesium: Possible Cellular Basis for the Differences in the Efficacy of magnesium and Lidocaine in Torsade de Pointes.
24633623 2014. Gating of the kir2.1 channel at the bundle crossing region by intracellular spermine and other cations.
27543914 2017. QTc prolongation during peripheral stem cell apheresis in healthy volunteers.
31116446 2019. Loperamide: A Readily Available but Dangerous Opioid Substitute.
7665716 1995. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.
1753009 1991. Electrophysiologic mechanisms for ventricular arrhythmias in left ventricular dysfunction: electrolytes, catecholamines and drugs.
12823094 2003. Oral magnesium ion shortens prolonged QTc interval.
27492745 2017. A multidisciplinary approach to prenatal treatment of congenital long QT syndrome.
20832817 2010. Torsades: adjacent and triggering electrocardiographic events.
9005884 1997. Torsade de pointes as a complication of subarachnoid hemorrhage: a critical reappraisal.
1735792 1992. Effect of strontium on action potential repolarization in rabbit sinoatrial node cells.
28755998 2017. Loperamide-Induced Torsades de Pointes: A Case Series.
28007361 2017. A Perfect Storm: Tyrosine Kinase Inhibitor-Associated Polymorphic Ventricular Tachycardia.
17976767 2008. Management of ventricular dysrhythmia secondary to trazodone overdose.
18022786 2008. Chronic methadone therapy complicated by torsades de pointes: a case report.
1491157 1992. Magnesium: clinical considerations.
9071844 1997. Combined use of astemizole and ketoconazole resulting in torsade de pointes.
11519837 2001. Alcoholic liver cirrhosis complicated with torsade de pointes during plasma exchange and hemodiafiltration.
11253252 2000. The electrocardiographic QT interval and its prolongation in response to medications: differences between men and women.
18846329 2008. Effects of potassium aspartate and magnesium on ventricular arrhythmia in ischemia-reperfusion rabbit heart.
8523384 1995. Two new culprits in cardiovascular disease: QT dispersion and aldosterone.
14508199 2003. Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis.
1316396 1992. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death.
15665255 2005. Magnesium deficiency in critical illness.
25073261 2013. Treatment of methadone-induced torsades de pointes with lidocaine.
19303883 2009. Role of Mg(2+) block of the inward rectifier K(+) current in cardiac repolarization reserve: A quantitative simulation.
17582433 2007. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.
11829056 2002. Actions of Androctonus australis and Leiurus quinquestriatus venoms in the rat isolated atria and anesthetized rats; effect of magnesium and lidocaine.
19967647 2009. Vascular calcification and QT interval in incident hemodialysis patients.
15211156 2004. Traumatic subarachnoid hemorrhage and QTc prolongation.
12755529 2003. Woman with postpartum ventricular tachycardia and hypomagnesemia.
24353019 2013. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain.
12354276 2002. Organophosphate poisoning complicated by a tachyarrhythmia and acute respiratory distress syndrome in a child.
9580612 1998. Gender difference in the cycle length-dependent QT and potassium currents in rabbits.
8355214 1993. Droperidol exerts dual effects on repolarization and induces early afterdepolarizations and triggered activity in rabbit Purkinje fibers.
15358992 2004. Magnesium homeostasis and antipsychotic-induced QTc prolongation.
14513929 2003. Antipsychotic induced prolongation of QTc interval treated with magnesium.
21677914 2011. Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia.
6471847 1984. EKG of the month. Torsades de pointes.
9140328 1997. Recurrent ventricular tachyarrhythmias associated with QT prolongation following hydrofluoric acid burns.
7837314 1995. Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity.
8230644 1993. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
1749066 1991. Treatment of torsade de pointes with intravenous magnesium in idiopathic long QT syndrome.
8973383 1996. Effects of antiarrhythmic agents and Mg2+ on aconitine-induced arrhythmias.
9057687 1996. Anticholinergic overdose induced torsade de pointes successfully treated with verapamil.
2724543 1989. Sheehan's syndrome with hypomagnesemia and polymorphous ventricular tachycardia.
7230515 1981. Etiology of QT prolongation and T wave changes in chronic alcoholism.
28294893 2016. [On Synergism of Potassium and Magnesium in Maintenance of Myocardial Function].
17495849 2007. [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration].
1479796 1992. Atypische Form eines Long-QT-Syndroms--ein Fallbericht.
8256055 1993. [A case of life-threatening ventricular arrhythmias probably due to psychotropic drugs].
1325665 1992. [Antiarrhythmic effects of magnesium on single ventricular myocytes].
1348867 1992. [A case of congenital long QT syndrome associated with T wave alternans].
2047605 1991. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
3532248 1986. [Clinical significance of QT interval].
8105332 1993. Does antiarrhythmic magnesium therapy enhance malarial infection?
31298598 2019. QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia.
7999530 1994. Antiarrhythmic effect of parenteral magnesium on ventricular tachycardia associated with long QT syndrome.
7999528 1994. Should magnesium therapy be considered for the treatment of coronary heart disease? I. A critical appraisal of current facts and hypotheses.
1296762 1992. New data on the antiarrhythmic value of parenteral magnesium treatment: magnesium and ventricular arrhythmias.
2693848 1989. Magnesium therapy of cardiac arrhythmias in critical-care medicine.
3523053 1986. Magnesium and cardiac arrhythmias.
15301336 2004. Acquired long QT syndrome and monomorphic ventricular tachycardia after alternative treatment with cesium chloride for brain cancer.
8189766 1994. Torsades de pointes ventricular tachycardia associated with overdose of astemizole.
28828702 2017. Vergiftungen mit psychotropen Substanzen.
27906148 2016. In brief: PPIs and Torsades de Pointes.
22970526 2012. Magnesium-Mangel und Arzneimittel.
15974204 2005. Bradycardia-associated torsade de pointes and the long-QT syndromes: a case report and review of the literature.
1407620 1992. Torsione di punta iatrogena indotta da tioridazina.
10783591 1999. Cisapride e rischio di complicanze cardiache.
11349326 2001. Herzrhythmusstorungen. Torsade de pointes durch Hypokaliamie.
8587608 1996. The inward rectification mechanism of the HERG cardiac potassium channel.
18648775 2008. An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.
17093009 2007. Sudden cardiac death in nephrology: focus on acquired long QT syndrome.
12053061 2002. QT dispersion in renal transplant recipients.
9578069 1998. Effect of hemodialysis on the dispersion of the QTc interval.
17003569 2006. Blockade of renin-angiotensin system reduces QT dispersion and improves intracellular Ca/Mg status in hemodialysis patients.
16166802 2006. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.
29923812 2018. The Identification of Torsades de Pointes via CEEG: A Case Report on a Patient with Physiologically Provoked Nonepileptic Events.
23452578 2013. QTc prolongation after brain surgery.
7993632 1994. Kir2.1 inward rectifier K+ channels are regulated independently by protein kinases and ATP hydrolysis.
18652879 2008. Elementary properties of Kir2.1, a strong inwardly rectifying K(+) channel expressed by pigeon vestibular type II hair cells.
18074575 2007. [Drug-induced long QT syndrome].
16001778 2005. [Long QT syndrome].
12136628 2002. [Drug-induced arrhythmias].
8810801 1996. [Drug-induced arrhythmias].
1685194 1991. [Torsade de pointes].
7476792 1994. Torsade de pointes and elevated magnesium and calcium requirements associated with intravenous pentamidine.
32086826 2020. Chemical cardioversion of atrial flutter and fibrillation in the pediatric population with Ibutilide.
27628760 2016. Provider Response to QTc Prolongation on Standard 12-Lead EKG: Do We Notice or Do We Care?
21039642 2013. Pregnancy and short-coupled torsades de pointes.
17976094 2007. Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.
16105013 2005. Effects of intravenous magnesium in a prolonged QT interval model of polymorphic ventricular tachycardia focus on transmural ventricular repolarization.
9604253 1998. Sotalol associated torsades de pointes tachycardia in a 15-month-old child: successful therapy with magnesium aspartate.
7681173 1993. Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.
7690949 1993. Torsades de pointes.
1376904 1992. TU alternans, long QTU, and torsade de pointes: clinical and experimental observations.
1721131 1991. Association of humps on monophasic action potentials and ST-T alternans in a patient with Romano-Ward syndrome.
1695751 1990. Magnesium therapy in ventricular arrhythmias.
25701242 2015. Hypomagnesemic down-regulation of L-type Ca(2+) channel in cardiomyocyte as an arrhythmogenic substrate in rats.
11922507 2002. Studies of magnesium in congenital long QT syndrome.
7784240 1995. Effective use of magnesium for acquired torsade de pointes in a 4-month-old infant.
17251875 2007. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.
24694881 2014. Acquired long QT syndrome: a focus for the general pediatrician.
15094576 2004. Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.
8247942 1993. Torsade de pointes.
8488140 1993. Torsade de pointes associated with Astemizole overdose treated with magnesium sulfate.
16635167 2006. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome.
23760993 2013. QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study.
12837909 2003. Iatrogenic acute hypermagnesemia after total parenteral nutrition infusion mimicking septic shock syndrome: two case reports.
19002489 2009. Human Kir2.1 channel carries a transient outward potassium current with inward rectification.
9019734 1996. Heterooligomeric assembly of inward-rectifier K+ channels from subunits of different subfamilies: Kir2.1 (IRK1) and Kir4.1 (BIR10).
15918160 2005. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
12076305 2002. Drug-induced ventricular tachyarrhythmia in isolated rabbit hearts with atrioventricular block.
29380488 2018. Validation and Clinical Utility of the hERG IC50:Cmax Ratio to Determine the Risk of Drug-Induced Torsades de Pointes: A Meta-Analysis.
29882591 2018. Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review.
17316157 2007. Management of dofetilide overdose in a patient with known cocaine abuse.
8643894 1996. Der klinisch-pharmakologische Fall (2).Bradykardie und ventrikulare Tachykardia vom Typ Torsade de pointes als Nebenwirkung von Vasopressin: drei Fallberichte.
7754271 1995. Magnesium in der Kardiologie.
3157959 1985. Torsades de pointes chez l'alcoolique.
3157953 1985. Traitement des torsades de pointes par le sulfate de magnesium.
12893979 2003. Why is the QT interval measurement so critical when evaluating an ECG rhythm?
16951992 2006. Effects of metal-binding properties of human Kv channel-interacting proteins on their molecular structure and binding with Kv4.2 channel.
19508229 2009. Functional roles of EF-hands in human potassium channel-interacting protein 2.2.
16901607 2006. Hypomagnesaemia causing QT interval prolongation and torsade de pointes in an alcoholic patient.
2326522 1990. Arritmia cardiaca grave secundaria a deplecion de magnesio. Torsade de pointe.
7209092 1980. Alternancia electrica de la onda T y "torsades de pointes".
23167136 2012. Le magnesium, applications en soins intensifs et en anesthesiologie.
31373450 2019. Torsade de pointe sur interaction medicamenteuse entre sotalol et ciprofloxacine.
28692217 2016. Le magnesium dans la pratique clinique quotidienne.
24024425 2013. Le QT long acquis.
2631832 1989. Eficacia terapeutica do sulfato de magnesio por via intravenosa em taquidisritmias. A proposito de quatro casos clinicos.
8497770 1993. Gefahrliche Rhythmusstorungen.
8421775 1993. Das "cardiac ballet" mit und ohne Amiodaron.
1699270 1990. Hemiparese und Torsade de pointes unter niedrigdosierter Therapie mit Sotalol.
3070741 1988. Magnesium in der Kardiologie. Grundlagen und mogliche Indikationen.
30620510 2016. [Long QT Syndrome Induced by Antidepressants].
9459289 1998. Hypomagnesemia: renal magnesium handling.
10709414 1999. Electrocardiographic case: a middle aged, seriously ill woman with an unusual ECG and wide complex tachycardia.
8266190 1993. Torsade de pointes and sudden death associated with diabetic autonomic diarrhoea--a case report.
11811859 2001. Magnesium: its proven and potential clinical significance.
10586828 1999. Magnesium for the next millennium.
9042182 1997. Hyperphosphatemia associated with phosphorus-containing laxatives in a patient with chronic renal insufficiency.
14963284 2004. Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage.
19418112 2009. QT interval prolongation among patients treated with angiogenesis inhibitors.
8091345 1993. Pathologie cardiovasculaire et magnesium.
2094063 1990. Effect of magnesium sulfate on ventricular refractoriness and its efficacy for torsade de pointes.
18067651 2007. Assessment of corrected QT interval in sickle-cell disease patients who undergo erythroapheresis.
20620555 2010. Torsades de pointes triggered by severe diastolic hypotension with low hematocrit in the neohepatic stage of liver transplantation: a case report.
10770105 1999. Torsade de pointes associated with encephalitis.
8701528 1996. Torsade de pointes-takykardi ved sotalolbehandling af en normokaliaemisk patient.
15287289 2004. Eclampsia and abnormal QTc.
18365152 2008. Medikamentos induzierte Verlangerung des QT-Intervalls.
11105328 2000. Der Stellenwert von Magnesium bei Herzrhythmusstorungen.
27878411 2018. Riskante Gabe von QT-Intervall-verlangernden Wirkstoffen bei alteren Patienten mit arzneimittelinduzierter Torsade de pointes.
9064959 1996. Magnesium: Aktuelle Studien--kritische Wertung--Konsequenzen.
9064958 1996. Magnesium als antiarrhythmisches Therapieprinzip bei supraventrikularen und ventrikularen Herzrhythmusstorungen.
7502575 1995. Sotalol-induzierte Torsade-de-Pointes-Tachykardien bei einem 15 Monate alten Kleinkind.
7863684 1994. Die Bedeutung von Magnesium in der Intensivmedizin.
8147050 1993. Torsade de pointes.
29926671 2018. [Anti-arrhythmic effects of taurine-magnesium coordination compound on torsades de pointes].
8404313 1993. [Classification and treatment of torsades de pointes (TdP): a report of 11 cases].
21624302 2011. [Clinical characteristics and outcome of 32 patients with long-QT syndrome accompanied with torsade de pointes].
21624301 2011. [Clinical characteristics of 52 patients with torsade de points associated with acquired QT prolongation].
17386161 2007. [The effects of calmodulin kinase II inhibitor on ventricular arrhythmias in rabbits with cardiac hypertrophy].
15932674 2005. [Calmodulin antagonist inhibits torsade de pointes induced by d-sotalol in an isolated rabbit heart model].
8854446 1995. Acquired long QT syndrome in a child undergoing craniotomy: a case report.
